CONCLUSION: Our study indicates the USP43/E2F1/NSDHL pathway as a key mechanism in cholesterol-mediated GEM resistance in BLCA, providing novel insights for therapeutic intervention to counteract chemoresistance. Here, NSDHL is linked to bladder transitional cell carcinoma.